Apple & Big Tech Increasingly Seek to Dominate Health-tech Wearables

Apple & Big Tech Increasingly Seek to Dominate Health-tech Wearables TrialsiteN

Apple continues to position itself toward dominance in the health wearables market by recruiting and hiring David Tsay, a leading cardiologist and professor of cardiology at Columbia University Medical Center. They also hired Alexis Beatty, previously with University of Washington.

A $3.5+ Trillion Industry

With the healthcare sector north of $3.5 trillion in the United States, Apple and other tech ventures vie for position in a quest for technological advantage leading to dominant position in what will continue to be a growing, powerful industry. “Big tech” ventures seek to own the health monitoring space—where health issues can be monitored in the move to maintain and manage health care spend.

Heart Disease

Massive numbers face some form of heart disease. The financial upside for those with winning health wearables in the health market represents vast business opportunities for those that are on the winning side. Google’s acquisition of Fitbit showcases this trend.

Big Tech

In addition to Apple, Alphabet (Google parent), Amazon and Facebook are in a race to position for the winning products. Targeted and select physicians, with subject matter expertise and technical know-how are in huge demand reports Worldnet Health.

Decentralized Clinical Trials

Biopharmaceutical sponsors will increasingly work with investigator sites to design protocols to not only make it easier for the clinical research site but importantly, more patient friendly. Known as patient-centric trials, a new class of clinical trial is now made possible by the convergence of cloud computing, big data, mobile technology platforms and smart phones, AI and machine learning and purpose-designed apps. Increasingly, we will see clinical trials that leverage real-world data including real-time patient data collection scenarios made possible by the largest tech vendors and their clinical apps. 

Call to Action: Remote or decentralized clinical trials are already here. Clinical research coordinators at the site should start learning about how purpose-built, validated mobile apps will help transform clinical research.